Neuroendocrine differentiation in basal cell carcinoma.

J Immunoassay Immunochem

a Department of Pathology , The La Rabta Hospital, Tunis University, Bab Saadoun, Tunis.

Published: January 2018

Basal cell carcinoma (BCC) is the prototypical basaloid tumor of the skin. It may show various patterns simulating other cutaneous tumors due to its pleomorphism. It may have an unusal pattern of differentiation such as squamous, sebaceous, apocrine, eccrine, pilar, and endocrine differentiation. In order to establish the relative frequency of neuroendocrine differentiation in BCC, we performed a retrospective study of 33 consecutive BCCs using conventional immunohistochemistry with two neuroendocrine antibodies: Chromogranine A and synaptophysine. The age of the patients ranged from 17-83 years with mean of 65 years. The male to female ratio was 16:17. In immunohistochimestry, Chromogranine A was seen in 72.2% (24/33) while Synaptophysine was positive in 9.09% (3/33). Their expression was cytoplasmic and membranous and was seen in the periphery of these tumors in the overlying cells. Positive staining of chromogranine A was high (75-100% of tumors cells) in 9%, intermediate (25-75% of tumors cells) in 33% of cases and relatively low (<25%) in 30.3% of cases.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15321819.2017.1331170DOI Listing

Publication Analysis

Top Keywords

neuroendocrine differentiation
8
basal cell
8
cell carcinoma
8
tumors cells
8
differentiation basal
4
carcinoma basal
4
carcinoma bcc
4
bcc prototypical
4
prototypical basaloid
4
basaloid tumor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!